Unrelated allogeneic hematopoietic stem cell transplantation in a patient with Revesz syndrome, a severe variant of dyskeratosis congenita.
作者信息
Watanabe Kentaro, Arakawa Yuki, Kambe Tomoka, Oguma Eiji, Kishimoto Hiroshi, Koh Katsuyoshi
机构信息
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Department of Ophthalmology, Saitama Children's Medical Center, Saitama, Japan.
出版信息
Pediatr Blood Cancer. 2019 Jan;66(1):e27476. doi: 10.1002/pbc.27476. Epub 2018 Sep 26.
PMID:30259646
Abstract
摘要
相似文献
1
Unrelated allogeneic hematopoietic stem cell transplantation in a patient with Revesz syndrome, a severe variant of dyskeratosis congenita.里维斯综合征（先天性角化不良的一种严重变异型）患者的非亲缘异基因造血干细胞移植。
Pediatr Blood Cancer. 2019 Jan;66(1):e27476. doi: 10.1002/pbc.27476. Epub 2018 Sep 26.
2
Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita.先天性角化不良的异基因造血干细胞移植
Curr Opin Hematol. 2016 Nov;23(6):501-507. doi: 10.1097/MOH.0000000000000290.
3
Novel mutation of the TINF2 gene resulting in severe phenotypic Revesz syndrome.导致严重表型的雷维斯综合征的TINF2基因新突变。
Pediatr Blood Cancer. 2019 Mar;66(3):e27557. doi: 10.1002/pbc.27557. Epub 2018 Nov 26.
4
Bilateral Exudative Retinopathy in a Child with Revesz Syndrome, a Severe Variant of Dyskeratosis Congenita.患有瑞维斯综合征（先天性角化不良的一种严重变体）的儿童双侧渗出性视网膜病变。
Ophthalmol Retina. 2021 Nov;5(11):1106. doi: 10.1016/j.oret.2021.08.002.
5
Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita.
Bone Marrow Transplant. 2016 May;51(5):744-6. doi: 10.1038/bmt.2015.333. Epub 2016 Jan 25.
6
Hematopoietic cell transplantation in Fanconi anemia and dyskeratosis congenita: A minireview.范可尼贫血和先天性角化不良中的造血细胞移植：一篇综述。
Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):285-289. doi: 10.1016/j.hemonc.2017.05.014. Epub 2017 Jun 15.
7
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita.非清髓性异基因造血干细胞移植治疗先天性角化不良
Bone Marrow Transplant. 2003 Mar;31(5):407-10. doi: 10.1038/sj.bmt.1703844.
8
Diffuse hemorrhagic colitis in a patient with dyskeratosis congenita after nonmyeloablative allogeneic hematopoietic stem cell transplantation.先天性角化不良患者非清髓性异基因造血干细胞移植后发生弥漫性出血性结肠炎。
J Pediatr Hematol Oncol. 2015 Jan;37(1):e41-4. doi: 10.1097/MPH.0000000000000208.
9
Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure.降低强度的预处理方案对于先天性角化不良相关的骨髓衰竭患者的造血干细胞移植是有效的。
Bone Marrow Transplant. 2013 Sep;48(9):1168-72. doi: 10.1038/bmt.2013.35. Epub 2013 Apr 1.
10
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.先天性角化不良患者异基因造血细胞移植的结果。
Biol Blood Marrow Transplant. 2013 Aug;19(8):1238-43. doi: 10.1016/j.bbmt.2013.05.021. Epub 2013 Jun 8.
引用本文的文献
1
Revesz syndrome revisited.重新审视雷维茨综合征。
Orphanet J Rare Dis. 2020 Oct 23;15(1):299. doi: 10.1186/s13023-020-01553-y.
Zotero 插件